Invesco Pharmaceuticals ETF
PJP
83 hedge funds and large institutions have $86.2M invested in Invesco Pharmaceuticals ETF in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 28 reducing their positions, and 15 closing their positions.
25% more capital invested
Capital invested by funds: $68.9M → $86.2M (+$17.3M)
6.44% more ownership
Funds ownership: 15.44% → 21.88% (+6.4%)
13% less funds holding
Funds holding: 95 → 83 (-12)
36% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 28
53% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$22.9M |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
+$10.5M |
| 3 |
FAAS
First Allied Advisory Services
San Diego,
California
|
+$1.14M |
| 4 |
MIH
Madison Investment Holdings
Madison,
Wisconsin
|
+$781K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$710K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$3.61M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.74M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.72M |
| 4 |
Jane Street
New York
|
-$1.55M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$982K |
PJP Hedge Fund Activity: Q2 2019 in Review
83 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q2 2019, worth a combined $86.2M — up 25% from $68.9M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of PJP and 7 opened new positions — a net loss of 8 holders — while 28 trimmed existing stakes and 18 added.
The largest buyer was Brinker Capital Investments, opening a new position worth an estimated $22.9M. The largest seller was Bank of America, cutting an estimated $3.61M.
- 83 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q2 2019, down from 95 in Q1 2019.
- Funds reported $86.2M of Invesco Pharmaceuticals ETF stock for Q2 2019, up 25% quarter-over-quarter.
- 7 funds opened new Invesco Pharmaceuticals ETF positions in Q2 2019 and 15 closed out, a net change of -8 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q2 2019 was Brinker Capital Investments, an estimated $22.9M added.
- The largest Invesco Pharmaceuticals ETF seller in Q2 2019 was Bank of America, an estimated $3.61M sold.
Based on aggregated 13F filings for Q2 2019.